Evidence map›Paper›PMID 33024089›Full record

ArticleNature communications2020

Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenes.

Stephan Brouwer, Timothy C Barnett, Diane Ly, Katherine J Kasper, David M P De Oliveira, Tania Rivera-Hernandez, Amanda J Cork, Liam McIntyre, Magnus G Jespersen, Johanna Richter and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 71 citations in OpenAlex.

  1. Tracing the recent evolution of Group AEmerging microbes & infections · 2026
    Review
  2. Review
  3. Article
  4. Comparing virulence profile of dominantInfectious diseases & immunity · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. T cells in Group AFrontiers in cellular and infection microbiology · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The burden of group AiScience · 2025
    Review
  20. Characterization ofMicroorganisms · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 6 countries.

Stephan Brouwer *Australian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia.
Timothy C Barnett *Australian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia.ORCID http://orcid.org/0000-0002-3346-5117
Diane LyIllawarra Health and Medical Research Institute, Wollongong, NSW, Australia.
Katherine J KasperDepartment of Microbiology and Immunology and the Centre for Human Immunology, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.
David M P De OliveiraAustralian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia.ORCID http://orcid.org/0000-0002-5085-7163
Tania Rivera-HernandezAustralian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia.
Amanda J CorkAustralian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia.
Liam McIntyreDepartment of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
Magnus G JespersenDepartment of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0001-9751-9877
Johanna RichterAustralian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia.
Benjamin L SchulzAustralian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia.
Gordon DouganThe Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
Victor NizetDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-3847-0422
Kwok-Yung YuenState Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, Hong Kong, China.ORCID http://orcid.org/0000-0002-2083-1552
Yuanhai YouState Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, 102206, China.
John K McCormickDepartment of Microbiology and Immunology and the Centre for Human Immunology, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.ORCID http://orcid.org/0000-0003-3742-7289
Martina L Sanderson-SmithIllawarra Health and Medical Research Institute, Wollongong, NSW, Australia.ORCID http://orcid.org/0000-0002-6366-4993
Mark R DaviesAustralian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia.ORCID http://orcid.org/0000-0001-6141-5179
Mark J WalkerAustralian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia. mark.walker@uq.edu.au.ORCID http://orcid.org/0000-0001-7423-2769
The University of Queensland · AUThe University of Melbourne · AUUniversity of Wollongong · AUWestern University · CANational Institute for Communicable Disease Control and Prevention · CNUniversity of California San Diego · USUniversity of Cambridge · GBUniversity of Hong Kong - Shenzhen Hospital · CN

Funding

CIHRWellcome Trust
6 · The paper itself

Abstract

The re-emergence of scarlet fever poses a new global public health threat. The capacity of North-East Asian serotype M12 (emm12) Streptococcus pyogenes (group A Streptococcus, GAS) to cause scarlet fever has been linked epidemiologically to the presence of novel prophages, including prophage ΦHKU.vir encoding the secreted superantigens SSA and SpeC and the DNase Spd1. Here, we report the molecular characterization of ΦHKU.vir-encoded exotoxins. We demonstrate that streptolysin O (SLO)-induced glutathione efflux from host cellular stores is a previously unappreciated GAS virulence mechanism that promotes SSA release and activity, representing the first description of a thiol-activated bacterial superantigen. Spd1 is required for resistance to neutrophil killing. Investigating single, double and triple isogenic knockout mutants of the ΦHKU.vir-encoded exotoxins, we find that SpeC and Spd1 act synergistically to facilitate nasopharyngeal colonization in a mouse model. These results offer insight into the pathogenesis of scarlet fever-causing GAS mediated by prophage ΦHKU.vir exotoxins.

Indexed as

AnimalsBacterial ProteinsCell LineErythrocytesExotoxinsFemaleGlutathioneHumansMaleMice, Inbred C57BLMice, TransgenicMutationPharynxProphagesScarlet FeverStreptococcus pyogenesBacterial ProteinsExotoxinsGlutathionestreptolysin OStreptolysinsSuperantigens

Identifiers

PMID33024089
PMCPMC7538557
OpenAlexW3092264786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.